share_log

Coya Therapeutics | 8-K: Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results

SEC ·  May 9 16:26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more